Covid-19 Pills to Become More Widely Available in U.S. – The Wall Street Journal
Covid-19 Pills to Become More Widely Available in U.S. The Wall Street JournalView Full Coverage on Google News
The U.S. has bought 3.1 million courses of molnupiravir, a Covid-19 pill from Merck and Ridgeback Biotherapeutics.
Photo: Rachel Wisniewski for The Wall Street Journal
